View in EDS

An oncogenic KRAS transcription program activates the RHOGEF ARHGEF2 to mediate transformed phenotypes in pancreatic cancer.

Saved in:
Bibliographic Details
Title: An oncogenic KRAS transcription program activates the RHOGEF ARHGEF2 to mediate transformed phenotypes in pancreatic cancer.
Authors: Kent OA; Princess Margaret Cancer Centre, University Health Network, Toronto Medical Discovery Tower, University of Toronto, Toronto, Canada., Sandí MJ; Princess Margaret Cancer Centre, University Health Network, Toronto Medical Discovery Tower, University of Toronto, Toronto, Canada., Burston HE; Princess Margaret Cancer Centre, University Health Network, Toronto Medical Discovery Tower, University of Toronto, Toronto, Canada., Brown KR; Donnelly Centre and Banting and Best Department of Medical Research, University of Toronto, Toronto, Canada., Rottapel R; Princess Margaret Cancer Centre, University Health Network, Toronto Medical Discovery Tower, University of Toronto, Toronto, Canada.; Department of Medicine, St. Michael's Hospital, Toronto, Canada.; Department of Medical Biophysics, St. Michael's Hospital, Toronto, Canada.; Department of Immunology, St. Michael's Hospital, Toronto, Canada.; Division of Rheumatology, St. Michael's Hospital, Toronto, Canada.
Source: Oncotarget [Oncotarget] 2017 Jan 17; Vol. 8 (3), pp. 4484-4500.
Publication Type: Journal Article
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 27835861
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: An oncogenic KRAS transcription program activates the RHOGEF ARHGEF2 to mediate transformed phenotypes in pancreatic cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kent+OA%22">Kent OA</searchLink>; Princess Margaret Cancer Centre, University Health Network, Toronto Medical Discovery Tower, University of Toronto, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22Sandí+MJ%22">Sandí MJ</searchLink>; Princess Margaret Cancer Centre, University Health Network, Toronto Medical Discovery Tower, University of Toronto, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22Burston+HE%22">Burston HE</searchLink>; Princess Margaret Cancer Centre, University Health Network, Toronto Medical Discovery Tower, University of Toronto, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22Brown+KR%22">Brown KR</searchLink>; Donnelly Centre and Banting and Best Department of Medical Research, University of Toronto, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22Rottapel+R%22">Rottapel R</searchLink>; Princess Margaret Cancer Centre, University Health Network, Toronto Medical Discovery Tower, University of Toronto, Toronto, Canada.; Department of Medicine, St. Michael's Hospital, Toronto, Canada.; Department of Medical Biophysics, St. Michael's Hospital, Toronto, Canada.; Department of Immunology, St. Michael's Hospital, Toronto, Canada.; Division of Rheumatology, St. Michael's Hospital, Toronto, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101532965%22">Oncotarget</searchLink> [Oncotarget] 2017 Jan 17; Vol. 8 (3), pp. 4484-4500.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Impact+Journals%22">Impact Journals </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101532965 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1949-2553 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219492553%22">19492553 </searchLink><i>NLM ISO Abbreviation: </i>Oncotarget <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27835861
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.18632/oncotarget.13152
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4484
    Titles:
      – TitleFull: An oncogenic KRAS transcription program activates the RHOGEF ARHGEF2 to mediate transformed phenotypes in pancreatic cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kent OA
      – PersonEntity:
          Name:
            NameFull: Sandí MJ
      – PersonEntity:
          Name:
            NameFull: Burston HE
      – PersonEntity:
          Name:
            NameFull: Brown KR
      – PersonEntity:
          Name:
            NameFull: Rottapel R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 01
              Text: 2017 Jan 17
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1949-2553
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Oncotarget
              Type: main
ResultId 1